CTRI/2024/02/062457
Not yet recruiting
未知
Role of Procalcitonin in guiding antibiotic therapy in moderate to severe acute pancreatitis - NI
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- A
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with the confirm diagnosis of moderate and severe acute pancreatitis
Exclusion Criteria
- •Admitted after 1 week of acute pancreatitis
- •Patient on antibiotic
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Procalcitonin-guided antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease (COPD) (AECOPD): a randomised trial - The ProCOLD StudyISRCTN77261143niversity Hospital Basel (Switzerland)200
Active, not recruiting
Not Applicable
Monitoring of antibiotic treatment of patients with suspected sepsis using the biomarker ProcalcitoniSepsisC01.539.757RBR-99h7tcniversidade Federal de Sergipe
Completed
Not Applicable
Procalcitonin-guided antibiotic therapy and hospitalisation in patients with lower respiratory tract infections: the ProHOSP studyISRCTN95122877niversity Hospital of Basel (Switzerland)1,002
Recruiting
Not Applicable
Procalcitonin-guided treatment regarding antibiotic use for acute COPD exacerbations: a prospective randomised controlled trialCOPD flare-upexacerbation COPD1002187910006436NL-OMON55985Erasmus MC, Universitair Medisch Centrum Rotterdam693
Not yet recruiting
Phase 3
The use of procalcitonin in patients of acute exacerbation of chronic obstructive disease in which people within intervention group will not receive antibiotic and will be seen for progression to severe disease, time to clinical resolution and days of antibiotic exposure in control group.CTRI/2024/05/068078Bharti